All Outputs (107)

Invisible suffering : breathlessness in and beyond the clinic—a reply (2015)
Journal Article
Hutchinson, A., Booth, S., Currow, D., Higginson, I., & Johnson, M. (2015). Invisible suffering : breathlessness in and beyond the clinic—a reply. The lancet. Respiratory medicine, 3(8), e29. https://doi.org/10.1016/S2213-2600%2815%2900232-5

Letter

Re: Asia, Australia and New Zealand Dyspnoea in Emergency Departments (AANZDEM) study: Rationale, design and analysis: Letters to the Editor (2015)
Journal Article
Currow, D. C., Hutchinson, A., & Johnson, M. J. (2015). Re: Asia, Australia and New Zealand Dyspnoea in Emergency Departments (AANZDEM) study: Rationale, design and analysis: Letters to the Editor. Emergency medicine Australasia : EMA, 27(5), 498-499. https://doi.org/10.1111/1742-6723.12429

Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: A feasibility pilot (2015)
Journal Article
Johnson, M. J., Simpson, M. I., Currow, D. C., Millman, R. E., Hart, S. P., & Green, G. (2015). Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: A feasibility pilot. BMJ open, 5(6), Article ARTN e007535. https://doi.org/10.1136/bmjopen-2014-007535

Objectives: Neuroimaging in chronic breathlessness is challenging. The study objective was to test the feasibility of magnetoencephalography (MEG) for functional neuroimaging of people with chronic breathlessness. Design: Feasibility pilot study. Set... Read More about Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: A feasibility pilot.

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? (2015)
Journal Article
Currow, D. C., Quinn, S., Ekström, M., Kaasa, S., Johnson, M. J., Somogyi, A. A., & Klepstad, P. (2015). Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?. BMJ open, 5(5), e006818-e006818. https://doi.org/10.1136/bmjopen-2014-006818

© 2015, BMJ Publishing Group. All rights reserved. Objectives: Opioids modulate the perception of breathlessness with a considerable variation in response, with poor correlation between the required opioid dose and symptom severity. The objective of... Read More about Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?.

A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: Implications for palliative care research (2015)
Journal Article
Boland, J., Currow, D. C., Wilcock, A., Tieman, J., Hussain, J. A., Pitsillides, C., Abernethy, A. P., & Johnson, M. J. (2015). A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: Implications for palliative care research. Journal of pain and symptom management, 49(4), 762-772. https://doi.org/10.1016/j.jpainsymman.2014.09.018

© 2015 American Academy of Hospice and Palliative Medicine. Context The challenges of palliative care clinical trial recruitment are well documented. Objectives The aim of the study was to review tested strategies to improve recruitment to trials of... Read More about A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: Implications for palliative care research.

Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction (2014)
Journal Article
Currow, D. C., Quinn, S., Agar, M., Fazekas, B., Hardy, J., McCaffrey, N., Eckermann, S., Abernethy, A. P., & Clark, K. (2015). Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. Journal of pain and symptom management, 49(5), 814-821. https://doi.org/10.1016/j.jpainsymman.2014.09.013

Context Does octreotide reduce vomiting in cancer-associated bowel obstruction? Objectives To evaluate the net effect of adding octreotide or placebo to standardized therapies on the number of days free of vomiting for populations presenting with vom... Read More about Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.

Clinically important differences in the intensity of chronic refractory breathlessness (2013)
Journal Article
Johnson, M. J., Bland, J. M., Oxberry, S. G., Abernethy, A. P., & Currow, D. C. (2013). Clinically important differences in the intensity of chronic refractory breathlessness. Journal of pain and symptom management, 46(6), 957-963. https://doi.org/10.1016/j.jpainsymman.2013.01.011

Context: Clinically important differences in chronic refractory breathlessness are ill defined but important in clinical practice and trial design. Objectives: To estimate the clinical relevance of differences in breathlessness intensity using distri... Read More about Clinically important differences in the intensity of chronic refractory breathlessness.